Massachusetts Medical Society: Question 7

Question 7

 

Question:

 

As compared with clopidogrel (Plavix), prasugrel (Effient) increases the risk of adverse cardiovascular events among acute coronary syndrome patients undergoing percutaneous coronary intervention.

 

 

 

Answers

Answer:

True
 

 

Correct Answer? 

 

Explanation:

 

Answers

Answer:

False
 

 

Correct Answer? 

 

Explanation:

Best answer: False. The TRITON-TIMI 38 study found that, as compared with clopidogrel plus aspirin, prasugrel plus aspirin reduced the rate of a composite endpoint comprising death from cardiovascular causes, nonfatal MI, and nonfatal stroke.  However, the rate of major bleeding events was higher in the prasugrel plus aspirin arm.

 

 

Format:

Radio buttons (single select)

 

Share on Facebook
Facebook logoLinkedInYouTube logoInstagramThreads

Copyright © 2025. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org